-
Maswanganyi Clarifies Pirates Allegiance Amidst Career Transition
-
Search Underway for 'Dooars Rani' Tigress After Second Escape from Buxa Tiger Reserve
-
Teatro Mayor Unveils 152-Performance 2027 Season Highlighting Beethoven and García Márquez
-
The Dilemma of Recording Live Music: Preserving Memories vs. Being Present
-
Rutgers Defeats NJIT 101-64 Behind Francis and Mark Scores
-
TAMKO and Kansas City Chiefs Announce 2026 Operation Rooftop Recipient
-
5E Advanced Materials to Host Fiscal First Quarter 2027 Earnings Conference Call on November 17, 2026
-
Patriot Software Adds Performance Reviews to Patriot HR
-
Protagenic Therapeutics Announces Private Placement of Up to $5 Million to Advance PT00114 into Its First U.S. Clinical Trial in Generalized Anxiety Disorder
-
Healixa's FrostPulse(TM) Technology Solves a Major Roadblock to Data Center Growth: Cooling Without the Water Burden
-
Route1 Announces 2026 Annual Meeting Results
-
NuRAN Wireless Board Approves Growth Strategy to Scale Recurring Revenue from 5,000+ Contracted Towers
-
Ethur Takes On Hiring Fraud With Facial Biometrics Identity Checks and Connected Payroll and Bank Data
-
PPX Mining Reports Callanquitas Operating Results for the First Nine Months of 2026
-
Green Leaf Innovations (OTC: GRLF) Meets OTCID Disclosure Requirements Following Profitable Q2 2026 Results
-
Valion Bio Reinforces Commitment to American Troops; Discusses Entolimod with Attendees at RW Baird's National Security Conference
-
XCF Global Hosts USDA at New Rise Renewables Reno as Facility Surpasses 4.4 Million Gallons Since Restart
-
Amarc Extends 2026 Exploration Program at the Duke District: Initiates Drilling Program at Established Porphyry Copper-Gold Targets
-
AmeriLife Welcomes Finance Veteran Richard Dziadzio as Chief Financial Officer; Names Jim Quinn President & Chief Transformation Officer
-
Trifecta Gold Reports 2026 Exploration Results from the Liam and Lois Projects, Tombstone Gold Belt, Yukon
-
Irving Resources Reports on Drilling in Yamagano Mining Right at the Yamagano Joint Venture, Kyushu, Japan
-
NiobiumX Mining Reports Results of Ground Radiometric Survey at Shipshaw, Maps Two Distinct Radiometric Signatures Across the Core Claims, and Moves to a High-Resolution Airborne Survey of the Full 2,686-Hectare Package
-
BlackBerry to Participate in Upcoming Investor Conferences
-
Christmas Day Shifts More than Double as Americans Return to In-Person Holiday Celebrations
-
THIEAUDIO Introduces Clairvoyance MKII: The Evolution of a Signature Sound
-
Fulcrum Metals PLC Announces Publication of Updated Investor Presentation
-
Guardian Metal Resources PLC Announces Proposed Spin-Out of Non-Tungsten Projects
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 11
-
Fulcrum Metals PLC Announces New Critical Mineral Recoveries Expand Potential
-
6 Pieces of Furniture Worth Investing In
-
Healthcare Leaders Identify Priorities for Agentic AI Adoption in 2027-2028 - Black Book
-
LogoTags, America's Leading Name in Custom Challenge Coins, Showcased at Kentucky Officers Leadership Symposium
-
SMX Advances AI Technology to Bring Greater Precision to Industrial Material Development
-
TripGift Unlocks Millions of Travel and Live Event Experiences for Corporate Rewards and Incentives in 117 Currencies
-
Leiər Introduces Passport, a New Fragrance Collection Debuting With Alba Eau De Parfum
-
WhalesBot Emphasizes Child Safety and Responsible AI Design in the Development of Pubbo
-
SMX Bridges AI and Industrial Material Science With New Intelligence Platform
-
Moderna Announces JAMA Network Open Publication of Real-World Comparative Effectiveness Data for mNEXSPIKE (COVID-19 Vaccine, mRNA) in Adults Aged 65 Years and Older
-
Sequoia Backs Microsoft Veterans' Edelbyte with $70M to Challenge Data Infrastructure Giants
-
Price Benowitz Earns 2027 Best Law Firm Recognition; 18 Attorneys Recognized by Best Lawyers
-
DaBella Honors More Than 200 Veteran Employees Nationwide This Veterans Day
-
ShelfieTech Announces Expansion Agreement for Its Next-Generation AI Retail Intelligence Platform
-
Resilient Energy Inc. (OTCID:RENI) Closes Acquisition of Mid River Midstream; Adds 12 Texas SWD Wells and $25M in Assets
-
SMX Expands Technology Portfolio With AI-Powered Scientific Intelligence Platform
-
LA Kush Cake Strain Guide Reviews Genetics and Historical Potency Data
-
Solid Aluminum, Deep Thock and 75% Compact Layout: Meet the Epomaker Galaxy75 Mechanical Keyboard
-
Who Is the Best Facial Feminization Surgeon?
-
CLS Health Advances Construction on New Webster Surgical Campus, Expanding Access to Care in Clear Lake Area
-
Cognitum One Launches Cognitum Spaces, the Governed System of Record for Physical Sites That Gives Enterprise AI Agents Trusted Real-World Context
-
OneMeta Provides Real-Time AI Translation for 2026 G20 Interfaith Forum Summit
Trump signs order reclassifying marijuana as less dangerous
US President Donald Trump said Thursday he was signing an executive order reclassifying marijuana as a less dangerous drug, in one of America's biggest shifts in drug policy for years.
The move stops short of full federal legalization for recreational use across the United States but is aimed at encouraging medical research on the use of cannabis products.
"Today, I'm pleased to announce that I will be signing an executive order to reschedule marijuana from a Schedule I to a Schedule III controlled substance with legitimate medical uses," Trump said in the Oval Office.
Marijuana is currently classified as a Schedule I substance -- in the same league as drugs like heroin and LSD. The US government considers these drugs to have high abuse potential without accepted use for medical treatment.
Schedule III substances, which include ketamine and anabolic steroids, are considered to have medical value and less potential for abuse.
Trump, who was surrounded by white-coated medical experts for the announcement, added that the order "is not the legalization" of marijuana "and no way sanctions its use as a recreational drug."
The teetotal 79-year-old added: "I've always told my children, don't take drugs, no drinking, no smoking, and just stay away from drugs."
Dozens of US states already have legal medical marijuana programs, and many also have approved its recreational use.
"A lot of people want to see it, the reclassification, because it leads to tremendous amounts of research that can't be done unless you reclassify, so we are looking at that very strongly," Trump said earlier this week.
Easing federal restrictions could have ripple effects, including lowering barriers to pursue research, as authorizing clinical studies on Schedule I substances can require many layers of approval.
It could also have major tax implications for companies that legally grow and sell cannabis.
US presidents cannot unilaterally reclassify a drug but Republican Trump's order directs Attorney General Pam Bondi to expedite the process.
Democrat Joe Biden's administration had previously pursued reclassification, but efforts stalled and were not completed before Trump took office in early 2025.
The US has a patchwork of state-level regulations regarding the commercial distribution, recreational possession and personal cultivation of cannabis.
In small amounts it is already legal for recreational use in 24 states as well as the capital Washington.
H.E.Young--AMWN